Stockreport

Edgewise Therapeutics to Present at the Leerink Partners Global Biopharma Conference on March 11, 2024

Edgewise Therapeutics, Inc.  (EWTX) 
PDF BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will [Read more]